Importance of genetic study in elderly patients with transthyretin cardiac amyloidosis
Med Clin (Barc). 2023 Nov 10;161(9):382-385.
doi: 10.1016/j.medcli.2023.06.023.
Epub 2023 Jul 31.
[Article in
English,
Spanish]
Affiliations
- 1 Unidad de Cardiopatías Familiares, Servicio de Cardiología, Complejo Asistencial Universitario de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL). Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, España. Electronic address: [email protected].
- 2 Servicio de Cardiología, Hospital Universitari Arnau de Vilanova. Institut de Recerca Biomédica de Lleida (IRBLleida), Lleida, España.
- 3 Unidad de Cardiopatías Familiares, Servicio de Cardiología, Complejo Asistencial Universitario de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL). Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, España.
- 4 Unidad de Cardiopatías Familiares, Servicio de Análisis Clínicos y Bioquímica Clínica, Unidad de Genética Molecular y Farmacogenética, Complejo Asistencial Universitario de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL), Salamanca, España.
Abstract
Background and objective:
Cardiac transthyretin amyloidosis (CA-ATTR) is a prevalent disease with age. Genetic study is recommended, even in eldest patients. We aim to analyze the prevalence of hereditary transthyretin amyloidosis (ATTRv) in elderly patients (≥75years) with CA-ATTR and its implications.
Patients and methodology:
Retrospective observational study of the cohort of elderly patients with CA-ATTR diagnosed according to the international recommended protocol. We analyze the results of sequencing TTR gene, the differential characteristics and their clinical implications.
Results:
Between 2016 and 2022, 130 elderly patients (89% cohort) were diagnosed with CA-ATTR (85% male). In 8 of the 123 patients with a genetic study, a pathogenic variant in TTR was identified (6.5%), initiating specific treatment in 4 subjects (50%). The family study identified another case and 6 asymptomatic carriers. There were no significant differences between baseline characteristics or in clinical events.
Conclusions:
The prevalence of ATTRv in elderly patients with CA-ATTR was 6.5% without observing differential characteristics that allow guiding a selective indication of genetic analysis.
Keywords:
Amiloidosis cardíaca; Cardiac amyloidosis; Consejo genético; Edad avanzada; Elderly; Genetic counselling; Transthyretin; Transtiretina.
Copyright © 2023 Elsevier España, S.L.U. All rights reserved.
Publication types
-
Observational Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Amyloid Neuropathies, Familial* / diagnosis
-
Amyloid Neuropathies, Familial* / genetics
-
Cardiomyopathies* / epidemiology
-
Cardiomyopathies* / genetics
-
Female
-
Genetic Testing
-
Humans
-
Male
-
Mutation
-
Prealbumin* / genetics
-
Prevalence
-
Retrospective Studies
-
Spain / epidemiology
Substances
-
Prealbumin
-
TTR protein, human
Supplementary concepts
-
Amyloidosis, Hereditary, Transthyretin-Related